MAGLIO, ANGELANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 152
AS - Asia 104
EU - Europa 86
SA - Sud America 16
AF - Africa 2
Totale 360
Nazione #
US - Stati Uniti d'America 148
SG - Singapore 91
IT - Italia 41
DE - Germania 15
BR - Brasile 14
FI - Finlandia 8
IE - Irlanda 5
SE - Svezia 5
CA - Canada 3
GB - Regno Unito 3
HK - Hong Kong 3
PK - Pakistan 3
AR - Argentina 2
CZ - Repubblica Ceca 2
FR - Francia 2
IN - India 2
NL - Olanda 2
TR - Turchia 2
BD - Bangladesh 1
CN - Cina 1
CY - Cipro 1
GR - Grecia 1
KE - Kenya 1
MX - Messico 1
PL - Polonia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 360
Città #
Singapore 74
Santa Clara 27
Munich 12
Chandler 10
Milan 8
Lawrence 6
Princeton 6
Ashburn 5
Chicago 5
Dublin 5
Naples 5
Turku 5
Wilmington 5
Palermo 4
Helsinki 3
Houston 3
London 3
Rome 3
San Nicola Manfredi 3
Ankara 2
Boardman 2
Boston 2
Dallas 2
Fisciano 2
Hanover 2
Hong Kong 2
Lamezia Terme 2
Messina 2
Miami 2
New York 2
Olomouc 2
Rio de Janeiro 2
Athens 1
Atlanta 1
Barreiras 1
Belo Horizonte 1
Brooklyn 1
Buffalo 1
Cataguases 1
Caucaia 1
Charlotte 1
Des Moines 1
Elba 1
Elk Grove 1
Erie 1
Garland 1
Hackensack 1
Huntersville 1
Indianapolis 1
Islamabad 1
Itaperuna 1
Jaraguá do Sul 1
Johannesburg 1
Karachi 1
Los Angeles 1
Luhansk 1
Marcianise 1
Mesquite 1
Mexico City 1
Milwaukee 1
Mumbai 1
Nairobi 1
Oxon Hill 1
Passa e Fica 1
Pontotoc 1
Porto Alegre 1
Puerto Rico 1
Raleigh 1
San Francisco 1
San Juan Bautista 1
Santa Maria 1
Senador Canedo 1
Sezze 1
Sorocaba 1
Stockholm 1
Surubim 1
Topeka 1
Toronto 1
Tulsa 1
Verdun 1
Warsaw 1
Totale 267
Nome #
Tezepelumab: A potential new biological therapy for severe refractory asthma 29
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 28
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 25
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 25
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 24
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 20
Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral 20
Novel Biological Therapies for Severe Asthma Endotypes 19
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 18
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 17
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 16
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 16
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 16
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 15
Phenotyping severe asthma: a rationale for biologic therapy 14
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 13
Novel Biological Therapies for Severe Asthma Endotypes 13
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 12
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 11
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 10
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 10
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 8
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 8
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 4
Totale 391
Categoria #
all - tutte 5.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 2 0 0 0 0 0 0 0 0
2021/202223 0 0 2 4 2 1 1 5 3 3 2 0
2022/202344 14 3 8 0 2 1 1 2 3 1 8 1
2023/202447 13 4 6 2 2 6 1 2 1 4 4 2
2024/2025245 22 4 0 4 32 43 13 7 13 4 41 62
2025/202629 29 0 0 0 0 0 0 0 0 0 0 0
Totale 391